KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Current Leases (2019 - 2025)

Evolent Health has reported Current Leases over the past 7 years, most recently at $15.3 million for Q4 2025.

  • Quarterly results put Current Leases at $15.3 million for Q4 2025, down 42.57% from a year ago — trailing twelve months through Dec 2025 was $15.3 million (down 42.57% YoY), and the annual figure for FY2025 was $15.3 million, down 42.57%.
  • Current Leases for Q4 2025 was $15.3 million at Evolent Health, down from $17.9 million in the prior quarter.
  • Over the last five years, Current Leases for EVH hit a ceiling of $35.2 million in Q1 2025 and a floor of $4.6 million in Q1 2023.
  • Median Current Leases over the past 5 years was $7.2 million (2021), compared with a mean of $11.7 million.
  • Biggest five-year swings in Current Leases: tumbled 52.03% in 2024 and later surged 294.72% in 2025.
  • Evolent Health's Current Leases stood at $7.1 million in 2021, then rose by 0.75% to $7.1 million in 2022, then skyrocketed by 36.73% to $9.7 million in 2023, then soared by 174.36% to $26.7 million in 2024, then tumbled by 42.57% to $15.3 million in 2025.
  • The last three reported values for Current Leases were $15.3 million (Q4 2025), $17.9 million (Q3 2025), and $24.2 million (Q2 2025) per Business Quant data.